What are the characteristics, diagnosis, and treatment of PALM-COEIN (Polyp, Adenomyosis, Leiomyoma, Malignancy and Hyperplasia, Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, and Not yet classified)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The PALM-COEIN classification system is the most effective approach to categorize and manage abnormal uterine bleeding (AUB) in women of reproductive age, as it encompasses both structural and non-structural causes 1.

Characteristics of PALM-COEIN

The PALM-COEIN system includes:

  • Structural causes (PALM):
    • Polyps: localized overgrowths of endometrial tissue
    • Adenomyosis: endometrial tissue growing into the myometrium
    • Leiomyoma: fibroids causing heavy bleeding and pelvic pressure
    • Malignancy and Hyperplasia: presenting with postmenopausal bleeding or irregular heavy bleeding
  • Non-structural causes (COEIN):
    • Coagulopathy: heavy bleeding since menarche
    • Ovulatory dysfunction: unpredictable bleeding patterns
    • Endometrial: heavy regular bleeding
    • Iatrogenic: medication side effects or IUD use
    • Not yet classified: rare conditions like arteriovenous malformations

Diagnosis of PALM-COEIN

Diagnosis of each cause involves:

  • Imaging studies such as ultrasound, MRI, or hysteroscopy
  • Hormone level testing and ultrasound monitoring for ovulatory disorders
  • Coagulation studies for coagulopathy
  • Endometrial biopsy for malignancy, hyperplasia, and endometrial disorders
  • History and physical examination for iatrogenic causes

Treatment of PALM-COEIN

Treatment options should be tailored to the specific cause of AUB, and may include medical management with progestin-only contraception, combined hormonal contraception, or other hormonal therapies, as well as surgical options such as polypectomy, myomectomy, or hysterectomy 1. Treatment options for each cause include:

  • Medical management with GnRH agonists, hormonal therapy, or hemostatic agents like tranexamic acid
  • Surgical options such as polypectomy, myomectomy, or hysterectomy
  • Endometrial ablation for heavy regular bleeding
  • Changing medications or removing/replacing IUDs for iatrogenic causes
  • Embolization or surgery for rare conditions like arteriovenous malformations

From the Research

Characteristics of PALM-COEIN

  • The PALM-COEIN classification system is used to define the underlying causes of abnormal uterine bleeding (AUB) in nonpregnant reproductive-aged women 2, 3, 4, 5, 6
  • The system categorizes the causes of AUB into two main groups: structural (PALM) and nonstructural (COEIN) entities 3, 4, 6
  • PALM refers to discrete structural entities, including:
    • Polyp
    • Adenomyosis
    • Leiomyoma
    • Malignancy and hyperplasia
  • COEIN refers to nonstructural etiologies, including:
    • Coagulopathy
    • Ovulatory dysfunction
    • Endometrial disorders
    • Iatrogenic
    • Not yet classified

Diagnosis of PALM-COEIN

  • A complete patient history is essential in the evaluation of AUB, combined with appropriate imaging, histopathologic analysis, or laboratory evaluation to ensure accurate diagnosis and treatment approaches 2
  • A focused menstrual history and pelvic examination are necessary to differentiate anovulatory bleeding from other causes of bleeding 4
  • Endometrial biopsy is indicated for women with AUB who are older than 45 years or have postmenopausal bleeding, as well as for those with specific risk factors for endometrial cancer 6

Treatment of PALM-COEIN

  • Management of AUB is determined by its etiology and typically consists of medical therapy, such as combination oral contraceptives, progestin-containing intrauterine devices, tranexamic acid, and nonsteroidal anti-inflammatory drugs 6
  • Patients with structural lesions may require surgical procedures, such as hysterectomy, myomectomy, or polypectomy 5
  • Management should be individualized, taking into account the patient's desire for current or future fertility 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Classification of menstrual bleeding disorders.

Reviews in endocrine & metabolic disorders, 2012

Research

Evaluation and management of abnormal uterine bleeding.

The Medical journal of Malaysia, 2022

Research

Comparison of classic terminology with the FIGO PALM-COEIN system for classification of the underlying causes of abnormal uterine bleeding.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.